Print this page

ECO35: Interference of hepatotoxicity with endocrine activity in fish

Principal Investigator

Prof. Dr. Thomas Braunbeck

Address:

Aquatic Ecology and Toxicology Group

Center for Organismal Studies

University of Heidelberg

Im Neuenheimer Feld 504

D-69120 Heidelberg

Germany

Tel: +49 6221 545668

E-mail: braunbeck@uni-hd.de

 

Collaborators

Helmut Segner, Prof. Dr., Vetsuisse Faculty Centre for Fish and Wildlife Health University of Berne, Bern, Switzerland

Henrik Holbech, Associate Prof. Dr., Department of Biology University of South Denmark at Odense, Denmark

Lennart Weltje, Dr., BASF SE, Limburgerhof, Germany

 

 

Description

The project proposed is driven by the hypothesis that hepatotoxicity may positively or negatively interfere with vitellogenin production, which is used as a key marker of endocrine activity in current OECD test guidelines 229, 230 and 234 and the proposed medaka extended one-generation test.

The purpose of the project is (1) to identify scenarios, where liver toxicity may affect the induction, synthesis and secretion of vitellogenin from hepatocytes in small fish models (preferentially zebrafish, but potentially also fathead minnow and medaka[1]). For this end, (2) the project will develop a set of diagnostic tools to distinguish primarily endocrine effects from secondary effects in consequence of liver toxicity. For selected modes of action, (3) Adverse Outcome Pathways (AOP) will be developed for liver toxicity-mediated modulation of the vitellogenin biomarker in fish.

[1]    To be discussed with LRI representatives; all species available at Heidelberg University.

The proposal will differentiate between the following scenarios:

(1).. impaired vitellogenin production in consequence of generalized degenerative processes of the liver (including VTG modulation by excessive test concentrations);

(2).. decreased vitellogenin production as a consequence of an impairment of general liver cell functionality (e.g. via reduction of protein synthesis capacities, disturbances of equilibrated lipoprotein synthesis, or energy depletion by, e.g. uncouplers).

The final deliverables of the project are:

  • Prove of principle that chemicals can modulate the endocrine endpoint “VTG” through a non-endocrine MOA ;
  • a diagnostic toolbox which enables the discrimination between endocrine- and non-endocrine-mediated changes of the VTG biomarker in fish;
  • AoPs for VTG-modulating chemicals with non-endocrine MOA.

Timeline: February 2016 > February 2018

LRI funding: € 254.052

Top

© Copyright 2014 Cefic | European Chemical Industry Council. All rights reserved | Terms and Conditions of Use